Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12

Rhea-AI Summary

Pharming Group (Euronext: PHARM / Nasdaq: PHAR) will report preliminary unaudited fourth quarter and full year 2025 financial results and provide a business update on March 12, 2026. Management will host a conference call and webcast at 13:30 CET / 08:30 EDT. Registration links and replay access are provided; only dial-in attendees can ask questions.

Key Figures

Earnings date: March 12, 2026 Conference call time CET: 13:30 CET Conference call time EDT: 08:30 am EDT +1 more

4 metrics

Earnings date March 12, 2026 Preliminary Q4 and full-year 2025 results release

Conference call time CET 13:30 CET Analyst and investor conference call

Conference call time EDT 08:30 am EDT Analyst and investor conference call

Results period Q4 and full year 2025 Preliminary (unaudited) financial results

Market Reality Check

normal vol

Market Pulse Summary

This announcement sets expectations for Pharming’s next information point, with preliminary (unaudit...

Analysis

This announcement sets expectations for Pharming’s next information point, with preliminary (unaudited) Q4 and full-year 2025 results and a business update scheduled for March 12, 2026. The planned conference call and webcast give analysts and investors a defined moment to reassess the company once financial details and management commentary are available. Until then, no additional financial metrics or trend data are provided in this release.

AI-generated analysis. Not financial advice.

Leiden, the Netherlands, February 26, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the fourth quarter and full year 2025 and provide a business update on Thursday, March 12, 2026.

Management will host a conference call and webcast for analysts and investors on the same day at 13:30 CET/08:30 am EDT.

To participate in the conference call or to watch the live webcast, please register in advance using the links below.

Conference call registration:
https://register-conf.media-server.com/register/BIb3649a77439d4a2d8e5e002bac980cd1

Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.

Please note, the Company will only take questions from dial-in attendees.

Webcast registration:
https://edge.media-server.com/mmc/p/ddxigjqm

The webcast will also be accessible on the Pharming website at Investors/Financial Documents, and a replay will be available shortly after the event.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Investor Relations
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

Media Relations
Global: Saskia Mehring, Corporate Communications Manager
T: +31 6 28 32 60 41
E: media.relations@pharming.com

U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)
T: +1 (917) 882-9038

Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27

Attachment

• Pharming Group to report 4Q25_FY25 results_EN_26FEB26

FAQ

When will Pharming (PHARM) report its Q4 and full-year 2025 results?

Pharming will report preliminary Q4 and full-year 2025 results on March 12, 2026. According to Pharming, management will also provide a business update the same day and host a conference call and webcast for analysts and investors.

What time is the Pharming (PHARM) March 12, 2026 conference call and webcast?

The conference call and webcast are scheduled for 13:30 CET / 08:30 EDT on March 12, 2026. According to Pharming, dial-in details and a unique PIN will be provided after registration for access to the live event.

How can investors register for the Pharming (PHARM) March 12, 2026 webcast?

Investors can register via the provided webcast registration link or the company's investor site. According to Pharming, once registered attendees receive dial-in information and a unique PIN, and a replay will be posted on the investor website after the event.

Will Pharming (PHARM) take live questions during the March 12, 2026 event?

Live questions will be taken only from dial-in attendees, not from the webcast. According to Pharming, participants must register to receive dial-in details and a unique PIN to submit questions during the conference call.

Where will the replay of the Pharming (PHARM) March 12, 2026 presentation be available?

A replay will be available shortly after the event on the Pharming investor website under Financial Documents. According to Pharming, the webcast will also be accessible via the registration link and the company’s investors page for later viewing.